Your browser doesn't support javascript.
loading
Kaguacidine A: a novel spirohydantoin-containing cucurbitane glycoside from vines of Momordica charantia L.
Huang, Hung-Tse; Lo, I-Wen; Lin, Yu-Chi; Geng-You, Liao; Lin, Yun-Sheng; Zhang, Li-Jie; Li, Tsung-Lin; Liaw, Chia-Ching; Kuo, Yao-Haur.
Afiliação
  • Huang HT; Division of Chinese Materia Medica Development, National Research Institute of Chinese Medicine, Taipei, Taiwan.
  • Lo IW; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Lin YC; Division of Chinese Materia Medica Development, National Research Institute of Chinese Medicine, Taipei, Taiwan.
  • Geng-You L; School of Medicine, Institute of Physiology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Lin YS; Department of Biological Science and Technology, Meiho University, Pingtung, Taiwan.
  • Zhang LJ; Division of Chinese Materia Medica Development, National Research Institute of Chinese Medicine, Taipei, Taiwan.
  • Li TL; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Liaw CC; Division of Chinese Materia Medica Development, National Research Institute of Chinese Medicine, Taipei, Taiwan.
  • Kuo YH; Department of Biochemical Science and Technology, National Chiayi University, Chiayi, Taiwan.
Nat Prod Res ; : 1-8, 2023 Jan 06.
Article em En | MEDLINE | ID: mdl-36606546
ABSTRACT
The spirohydantoin-containing cucurbitane-type triterpenoid, kaguacidine A (1), was isolated and purified from 95% ethanol extract of vines of Momordica charantia L. (Cucurbitaceae). Its unprecedented chemical structure, a spirohydantoin substituent at C-23 of cucurbitane, was elucidated by extensive spectroscopic analyses, including HRESIMS, IR, optical rotation, 1 D- and 2 D-NMR spectra. The possible biosynthetic pathway is deduced and may be attributed to the metabolic activity of microbial symbionts in M. charantia L. Compound 1 was evaluated for anti-inflammatory activity against LPS-induced NO production in RAW 264.7 cells and anti-proliferative activity against four cancer cell lines, including HEp-2, MCF-7, Hep-G2, and WiDr. Compound 1 showed moderate anti-inflammatory activity with an IC50 value of 18.5 ± 0.4 µg/mL and weak anti-proliferative activity against MCF-7, HEp-2, Hep-G2, and WiDr with IC50 values of >40, 33.8 ± 0.6, 31.0 ± 0.7, and 27.0 ± 0.7 µM, respectively.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Prod Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Prod Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan